Featured Article

Call to Action Issued to Address Ongoing Osteoporosis Treatment Crisis

Call to Action Issued to Address Ongoing Osteoporosis Treatment Crisis

Kenneth Saag, MD, president of the National Osteoporosis Foundation (NOF), co-chair of the National Bone Health Alliance, and Rheumatology Advisor advisory board member, reports on the recent changes that have led to the current state of osteoporosis treatment in the US.

Latest News

Femoral Nerve Block Alone or in Combination With Sciatic Nerve Block for TKA: A Meta-Analysis

Femoral Nerve Block Alone or in Combination With Sciatic Nerve Block for TKA: A Meta-Analysis

Sciatic nerve block may represent an effective complement to femoral nerve block for total knee arthroplasty.

Crysvita Approved for the Treatment of X-Linked Hypophosphatemia

Crysvita Approved for the Treatment of X-Linked Hypophosphatemia

Crysvita is an antibody that blocks fibroblast growth factor 23 (FGF23), a hormone that causes phosphate urinary excretion and suppresses active vitamin D production by the kidney.

USPSTF Issues Recommendation for Vitamin D, Calcium Supplementation for Fracture Prevention

USPSTF Issues Recommendation for Vitamin D, Calcium Supplementation for Fracture Prevention

The USPSTF has released recommendations for vitamin D and calcium supplementation for the primary prevention of fractures in community-dwelling adults.

Diabetes Does Not Alter Anti-osteoporotic Treatment Response

Diabetes Does Not Alter Anti-osteoporotic Treatment Response

Anti-osteoporotic medications (mainly bisphosphonates) seem to equally prevent bone loss, especially in the lumbar spine, in patients with diabetes compared with patients without diabetes.

Multimodal Analgesia After Knee, Hip Arthroplasty and Perioperative Outcomes

Multimodal Analgesia After Knee, Hip Arthroplasty and Perioperative Outcomes

Multimodal analgesia after hip or knee arthroplasty may be associated with fewer complications and reduced opioid prescriptions and hospital length of stay, compared with unimodal analgesia.

Thiazide Diuretic Use May Reduce Risk for Bone Fracture

Thiazide Diuretic Use May Reduce Risk for Bone Fracture

Results from a meta-analysis found that thiazides have a significant protective effect on fracture risk.

Type 2 Diabetes Associated With Increased Fracture Risk in Postmenopausal Women

Type 2 Diabetes Associated With Increased Fracture Risk in Postmenopausal Women

Type 2 diabetes may be associated with an increased risk for a major osteoporotic fracture in postmenopausal women.

Increased Bone Formation in Osteoporosis With Teriparatide vs Zoledronic Acid

Increased Bone Formation in Osteoporosis With Teriparatide vs Zoledronic Acid

Treatment of osteoporosis with teriparatide is linked to greater bone formation compared with zoledronic acid.

Bariatric Surgery Associated With Risk for Nonvertebral Fractures

Bariatric Surgery Associated With Risk for Nonvertebral Fractures

Gastric bypass surgery was associated with increased risk for nonvertebral fractures.

Bone Mineral Density Assessed in Young Adults With Prader-Willi Syndrome

Bone Mineral Density Assessed in Young Adults With Prader-Willi Syndrome

Compared with growth hormone treatment, 1 year of placebo after attainment of adult height does not decrease bone mineral density in young adults with Prader-Willi syndrome.

Sign Up for Free e-newsletters